Skinopathy Inc. is happy to welcome Abe Evreniadis as the first member to our newly established Board of Advisors.
Mr. Evreniadis is both an accomplished financier and leader in the community. Not only has he worked extensively for a number of Fortune 500 companies in mergers & acquisitions, joint ventures, and corporate development, but he has also steered recognizable portfolios with some of Canada’s largest banks.
However, his passion lies in healthcare.
For the last 13 years Mr. Avreniadis has led the Geneva Centre of Autism as a Board Member where he was actively involved in their Audit & Real Estate Committees, Governance, and now sits as their CEO. He also founded Sonderly.io, a leading international E-Learning platform focused on autism and mental health training for educators.
His work as a healthcare maven garnered the attention of the Ontario Medical Association where he currently serves on as a Board Member and is part of their Working Group for Adult Mental Health.
“It is a tremendous honour to have Abe join our Advisory Board,” says Keith Loo, Skinopathy Inc. CEO and Co-Founder. “He has been a NorthStar bridging healthcare innovation and savvy business acumen for many years, and we’re lucky to have him on our team.”
Needless to say, his experience, network, and desire to improve healthcare in Canada and internationally is a welcomed addition to the team. His presence has already been felt and we are eager to further integrate his knowledge directly into the very fabric that makes Skinopathy Inc. one of the more exciting medical start-ups in Canada.
Read Abe’s bio here.